Vascular endothelial growth factors and receptors in colorectal cancer: Implications for anti-angiogenic therapy

This publication has 24 references indexed in Scilit:

• Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
  New England Journal of Medicine, 2004
• VEGF receptor expression and signaling in human bladder tumors
  Oncogene, 2003
• Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
  Journal of Clinical Oncology, 2002
• Vascular Endothelial Growth Factor-Mediated Autocrine Stimulation of Prostate Tumor Cells Coincides with Progression to a Malignant Phenotype
  The American Journal of Pathology, 2001
• Quantitative Analysis of Gene Expressions of Vascular Endothelial Growth Factor-Related Factors and Their Receptors in Renal Cell Carcinoma.
  The Tohoku Journal of Experimental Medicine, 2001
• Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
  Oncogene, 2000
• VEGFs, receptors and angiogenesis
  Seminars in Cancer Biology, 1999
• Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
  Proceedings of the National Academy of Sciences, 1998
• Proteolytic processing regulates receptor specificity and activity of VEGF-C
  The EMBO Journal, 1997
• Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
  JNCI Journal of the National Cancer Institute, 1995